UW Department of Psychiatry and Behavioral Sciences
News
UW researchers prepare experimental fentanyl vaccine for human testing
The Daily | October 20, 2026
"When deciding whether a candidate is ready to advance, selectivity, safety, and manufacturability are three essential considerations," says Marco Pravetoni, PhD.
Feature
New institute streamlines pathways from discovery to impact
Department News | September 24, 2026
By integrating AI, experimental science, and interdisciplinary training, the new Institute for Innovations in Drug Disposition and Delivery (I2D3) will accelerate drug discovery and improve how medicines are manufactured (or formulated) and delivered, ensuring they reach the right place in the body with greater safety, effectiveness, and precision.
Events
Grand Rounds - Interventional psychiatry: Neurocircuits, evidence, and the emerging frontier
October 30 | 12 -1 PM
Dr. Michael Schrift will provide an accessible overview of interventional psychiatry, critically examine the evidence supporting established and emerging treatments, and discuss their clinical applications, limitations, and safety considerations.
